左心室のダイアストリック機能の評価

Same author

Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.

Circulation·1999

Same author

Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.

The American journal of physiology·1999

Same author

Phospholamban-to-SERCA2 ratio controls the force-frequency relationship.

The American journal of physiology·1999

Same author

Cellular mechanisms for the slow phase of the Frank-Starling response.

Journal of electrocardiology·1999

Same author

Mechanisms of length history-dependent tension in an ionic model of the cardiac myocyte.

The American journal of physiology·1998

Same author

Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes.

Circulation research·1997

Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026

Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026

Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026

Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026

Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026

Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026

関連する実験動画

左心室のダイアストリック機能の評価

関連する概念動画

Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.

Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.

Phospholamban-to-SERCA2 ratio controls the force-frequency relationship.

Cellular mechanisms for the slow phase of the Frank-Starling response.

Mechanisms of length history-dependent tension in an ionic model of the cardiac myocyte.

Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

関連する実験動画

左心室のダイアストリック機能の評価

関連する概念動画

関連記事

Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.

Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.

Phospholamban-to-SERCA2 ratio controls the force-frequency relationship.

Cellular mechanisms for the slow phase of the Frank-Starling response.

Mechanisms of length history-dependent tension in an ionic model of the cardiac myocyte.

Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.